Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dextromethorphan/Quinidine for Irritability in Huntington's Disease
NCT03854019Phase 3Completed
- Sponsor
- UTHealth Houston
- Start
- Aug 2019
- Primary completion
- Nov 2022
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dextromethorphan + quinidine in irritability, sponsored by UTHealth Houston. Started Aug 2019; status: completed.
02
Drugs
dextromethorphan + quinidine
03
Conditions
irritability
Beyond the preview
Go deeper on NCT03854019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03854019.